首页> 美国卫生研究院文献>Scientific Reports >PPARβ/δ a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats
【2h】

PPARβ/δ a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats

机译:PPARβ/δ蛛网膜下腔出血后大鼠血管平滑肌细胞表型调节和血管重塑的新型调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cerebral vascular smooth muscle cell (VSMC) phenotypic switch is involved in the pathophysiology of vascular injury after aneurysmal subarachnoid hemorrhage (aSAH), whereas the molecular mechanism underlying it remains largely speculative. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) has been implicated to modulate the vascular cells proliferation and vascular homeostasis. In the present study, we investigated the potential role of PPARβ/δ in VSMC phenotypic switch following SAH. Activation of PPARβ/δ by GW0742 and adenoviruses PPARβ/δ (Ad-PPARβ/δ) significantly inhibited hemoglobin-induced VSMC phenotypic switch. However, the effects of PPARβ/δ on VSMC phenotypic switch were partly obstacled in the presence of , a potent inhibitor of Phosphatidyl-Inositol-3 Kinase-AKT (PI3K/AKT). Furthermore, following study demonstrated that PPARβ/δ-induced PI3K/AKT activation can also contribute to Serum Response Factor (SRF) nucleus localization and Myocardin expression, which was highly associated with VSMC phenotypic switch. Finally, we found that Ad-PPARβ/δ positively modulated vascular remodeling in SAH rats, i.e. the diameter of basilar artery and the thickness of vessel wall. In addition, overexpression of PPARβ/δ by adenoviruses significantly improved neurological outcome. Taken together, this study identified PPARβ/δ as a useful regulator for VSMC phenotypic switch and vascular remodeling following SAH, providing novel insights into the therapeutic strategies of delayed cerebral ischemia.
机译:脑血管平滑肌细胞(VSMC)表型转换参与动脉瘤性蛛网膜下腔出血(aSAH)后血管损伤的病理生理学,而其背后的分子机制仍在很大程度上是推测性的。过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)参与调节血管细胞增殖和血管稳态。在本研究中,我们调查了SAH后PPARβ/δ在VSMC表型转换中的潜在作用。 GW0742和腺病毒PPARβ/δ(Ad-PPARβ/δ)激活PPARβ/δ可显着抑制血红蛋白诱导的VSMC表型转换。然而,PPARβ/δ对VSMC表型转换的影响在存在一种有效的磷脂酰肌醇3激酶-AKT抑制剂(PI3K / AKT)的情况下受到了部分阻碍。此外,以下研究表明,PPARβ/δ诱导的PI3K / AKT激活也可能有助于血清反应因子(SRF)的细胞核定位和心肌表达,这与VSMC表型转换高度相关。最后,我们发现Ad-PPARβ/δ积极调节SAH大鼠的血管重构,即基底动脉的直径和血管壁的厚度。此外,腺病毒过度表达PPARβ/δ可显着改善神经功能。两者合计,这项研究确定PPARβ/δ是SAH后VSMC表型转换和血管重塑的有用调节剂,为延迟性脑缺血的治疗策略提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号